In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC), announces the following meeting of the aforementioned review group:
Times and Date: 10 a.m.-11:30 a.m., May 21, 2009 (Closed).
Status: The meeting will be closed to the public in accordance with provisions set forth in sections 552b(c)(4) and (6), Title 5, U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to section 10(d) of Public Law 92-463.
Purpose: This group is charged with providing advice and guidance to the Start Printed Page 20327Secretary, Department of Health and Human Services, and the Director, CDC, concerning the scientific and technical merit of grant and cooperative agreement applications received from academic institutions and other public and private profit and nonprofit organizations, including State and local government agencies, to conduct specific injury research that focuses on prevention and control.
Matters To Be Discussed: The meeting will include the reporting and voting of the peer reviews conducted in response to Fiscal Year 2009 Requests for Applications related to the following individual research announcements: (1) RFA-CE-09-005, Research Priorities in Acute Injury Care (RO1), (2) RFA-CE-09-007 Research Grants for Preventing Violence and Violence-Related Injury (RO1), (3) RFA-CE09-004, Unintentional Poisoning from Prescription Drug Overdoses in Adults (R21), (4) RFA-CE-09-002, Adaptations of Evidence-Based Parenting Programs to Engage Fathers in Maltreatment Prevention (UO1), (5) RFA-CE-09-008, Identifying Neighborhood Level Protective and Promotive Factors for Youth Violence (UO1), (6) RFA-CE-09-009, Youth Violence Prevention through Economic, Environmental, and Policy Change (UO1), (7) RFA-CE-09-003, Preventing Sexual Violence Perpetration: Targeting Modifiable Risk Factors (UO1), (8) RFA-TS-09-002, Disease Progression in Persons Exposed to Asbestos Contaminated Vermiculite Ore in Marysville, Ohio (RO1), (9) RFA-TS-09-001, Libby, Montana Amphibole Epidemiology Research Program (RO1), (10) RFA-EH-09-002, “Program to Expand State Public Health Laboratory Capacity for Newborn Bloodspot Screening (UO1), (11) RFA-EH-09-003, Program to Enhance State Public Health Laboratory Capacity for Newborn Bloodspot Screening (UO1).
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Rick Waxweiler, PhD, Director, Extramural Research Program Office, National Center for Injury Prevention & Control and Executive Secretary, NCIPC IRG, CDC, 4770 Buford Highway, NE., M/S F-62, Atlanta, Georgia 30341, telephone 770-488-4850.
The Director, Management Analysis and Services Office has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both CDC and the Agency for Toxic Substances and Disease Registry.Start Signature
Dated: April 24, 2009.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.
[FR Doc. E9-10028 Filed 4-30-09; 8:45 am]
BILLING CODE 4163-18-P